Gly TR Therapeutics
GlyTR Therapeutics is an early-stage biotech company based in Irvine, CA, focused on developing a novel class of immunotherapeutic anticancer molecules and cells that are antibody-independent. Their platform technology aims to generate bispecific proteins and chimeric antigen receptor T cells, effectively targeting cancer antigens that are abnormally expressed across various types of cancer.
By addressing the limitations of current antibody-based immunotherapies, GlyTR's innovative approach seeks to induce the killing of multiple solid and blood cancers, ranging from breast cancer to leukemia. The company is dedicated to transforming cancer treatment and is eager to collaborate with leaders in cancer care research.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2024. All rights reserved.